Osi Bilbao-Basurto

Bilbao, Basque Country 48013

1 studies enrolling now · 5 studies all time

What they study most

Advanced Breast Cancer, Arthritis, Autoimmune Diseases, Breast Cancer, Connective Tissue Diseases, Immune System Diseases, Joint Diseases, Musculoskeletal Diseases, Rheumatic Diseases, Rheumatoid Arthritis

Studies at this site

• A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. — Recruiting now
• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
• Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease — Running, not enrolling
• A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer — Running, not enrolling
• A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis — Stopped early